Literature DB >> 6405248

[Molsidomin in coronary disease. Clinico-pharmacokinetic correlation study on the effect of oral and sublingual therapy].

R Strasser, H Klepzig, J Ostrowski, K Resag.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6405248

Source DB:  PubMed          Journal:  MMW Munch Med Wochenschr        ISSN： 0341-3098


× No keyword cloud information.
  4 in total

1.  Intravenous and oral administration of molsidomine, a pharmacodynamic and pharmacokinetic study.

Authors:  R Bergstrand; A Vedin; C Wilhelmsson; L E Peterson; J Chamberlain; D Dell; L A Stevens; J Ostrowski
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

2.  Clinical pharmacokinetics of molsidomine.

Authors:  B Rosenkranz; B R Winkelmann; M J Parnham
Journal:  Clin Pharmacokinet       Date:  1996-05       Impact factor: 6.447

3.  Pharmacokinetics of an extended-release dosage form of molsidomine in patients with coronary heart disease.

Authors:  J Ostrowski; G Gaul; D Voegele; D Brockmeier; K Resag
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

4.  A pilot double-blind randomized placebo-controlled study of molsidomine 16 mg once-a-day in patients suffering from stable angina pectoris: correlation between efficacy and over time plasma concentrations.

Authors:  Roger Messin; Tamas Fenyvesi; Fabienne Carreer-Bruhwyler; Jacques Crommen; Patrice Chiap; Philippe Hubert; Claude Dubois; Jean-Pierre Famaey; Joseph Géczy
Journal:  Eur J Clin Pharmacol       Date:  2003-05-07       Impact factor: 2.953
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.